Clinical Trial Update: Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating potential drug-drug interaction between lobeglitazone and empagliflozin in individuals with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Lobeglitazone (lobeglitazone)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Diabetes Mellitus, Type II | Phase 1 | Status: UNKNOWN